Sponsor or institution
Clinical trials and research at Faknostics, LLC
As of November 12, 2026, Find a Trial lists 7 NIH-funded research projects at this institution, with $4.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7NIH research projects
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Non-catalytic FAK inhibitors for lung fibrosis
A new treatment approach is being explored to slow or reverse lung fibrosis by targeting FAK proteins that drive stiffening and scarring in IPF patients.
-
Novel Paxillin-FAK Inhibitors for Liver Fibrosis
A new program is testing Paxillin-FAK inhibitors to slow or stop liver fibrosis in adults with liver diseases like alcoholic liver disease and MASH.
-
New drugs targeting paxillin and FAK to slow liver scarring
New medicines that block the paxillin and FAK proteins are being developed to slow or reverse liver scarring in adults with alcoholic liver disease and related chronic liver conditions.
-
Drugs that block FAK to treat lung scarring (pulmonary fibrosis)
A new type of medicine that blocks a protein called FAK aims to reduce or reverse lung scarring in people with pulmonary fibrosis.
-
New treatments for lung fibrosis using FAK inhibitors
This study is exploring new treatments for idiopathic pulmonary fibrosis (IPF) by targeting a protein that contributes to lung scarring, with the hope of helping patients breathe better and feel healthier.
-
New treatments for liver fibrosis using specific inhibitors
This study is looking at new ways to help people with liver fibrosis by blocking certain proteins that cause liver damage, with the hope of slowing down or even reversing the condition.
-
Creating new peptide inhibitors to target Focal Adhesion Kinase in melanoma treatment
This study is looking at new ways to stop melanoma, a serious skin cancer, by creating special proteins that can block a key part of the cancer's growth, which could lead to better treatments and improved lives for patients with advanced melanoma.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.